• No results found

[PDF] Top 20 Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia

Has 10000 "Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia" found on our website. Below are the top 20 most common "Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia".

Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia

Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia

... p = 0.005). Also the number of responding HIV-negative children (83%) was signifi cantly greater than that observed in the HIV-negative adults (69%; p = 0.05). Anti-D therapy at doses given was again shown to be ... See full document

6

<p>Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease</p>

<p>Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease</p>

... the treatment of several conditions including immune thrombocytopenia (ITP), 4,5 aplastic anemia, 6,7 thrombocytopenia associated with chronic hepatitis C infection, 8 and as a preprocedural ... See full document

9

Comparison of High Dose Dexamethasone and Prednisone for Initial Treatment of Adult Primary Immune Thrombocytopenia

Comparison of High Dose Dexamethasone and Prednisone for Initial Treatment of Adult Primary Immune Thrombocytopenia

... first-line treatment for adult primary immune thrombocytopenia ...of treatment were observed in either ...initial treatment with HD-DXM produced longer response duration compared to a ... See full document

5

Treatment with Megestrol Acetate Improves Human Immunodeficiency Virus-Associated Immune Thrombocytopenia

Treatment with Megestrol Acetate Improves Human Immunodeficiency Virus-Associated Immune Thrombocytopenia

... of immune cytopenias, and in such disorders, the beneficial effects of glucocorticoids are in part mediated by decreased expression of macrophage Fc ␥ ...HIV-associated thrombocytopenia with shortened ... See full document

5

Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia

Long-term safety and efficacy of romiplostim for treatment of immune thrombocytopenia

... Abstract: Inhibition of platelet production and mediated by antiplatelet antibodies is a well- known mechanism causing low platelet counts in immune thrombocytopenia (ITP). Use of thrombopoietin receptor ... See full document

8

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo controlled trials

Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: Results of two phase 3, randomized, placebo controlled trials

... with immune thrombocytopenia ...on treatment) occurred in 43% of patients on fostamatinib ...(antihypertensive, anti-motility ...ITP treatment option that targets an important mechanism ... See full document

10

Romiplostim as a treatment for immune thrombocytopenia: a review

Romiplostim as a treatment for immune thrombocytopenia: a review

... “Immune thrombocytopenia” (ITP) is an autoimmune disorder that leads to peripheral destruction, as well as a decreased production of ...for thrombocytopenia in adults with ...treat ... See full document

8

Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales

Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales

... to treatment with romiplostim were assumed to have a duration of treatment based on the empirical data from the eltrombopag ...on treatment duration would improve the robustness of the ... See full document

49

Patient-reported treatment burden of chronic immune thrombocytopenia therapies

Patient-reported treatment burden of chronic immune thrombocytopenia therapies

... a treatment effect that was not listed or could respond that no treatment side effects were ...selected treatment effect, the automated web-survey allowed patients to indi- cate their level of bother ... See full document

8

Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia

Spotlight on eltrombopag in the treatment of children with chronic immune thrombocytopenia

... studies, treatment with daily eltrombopag was associated with the development of cataracts in some patients, but many of these patients were also treated with significant amounts of prior steroid therapy so that ... See full document

5

Treatment of immune thrombocytopenia as an extra hepatic manifestation in an HCV carrier man with normal liver function test  A case report

Treatment of immune thrombocytopenia as an extra hepatic manifestation in an HCV carrier man with normal liver function test A case report

... follows: thrombocytopenia may be present even in the absence of clinically evident liver disease orsplenomegaly and may be mistakenly diagnosed as Garcia-Suarez et ...the treatment of ITP as an extra ... See full document

5

&lt;p&gt;Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use&lt;/p&gt;

<p>Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use</p>

... suggest treatment decisions should be based on bleeding symptoms and other risk factors rather than platelet ...1 Treatment is war- ranted in children who experience mucosal bleeding and are at risk of ... See full document

14

Refractory immune thrombocytopenia successfully treated with high dose vitamin D supplementation and hydroxychloroquine: two case reports

Refractory immune thrombocytopenia successfully treated with high dose vitamin D supplementation and hydroxychloroquine: two case reports

... Current treatment involves intravenous corticosteroids, immunosuppressants such as mycophenolate mofetil and azathioprine, Cytoxan W (cyclophosphamide), and intraven- ous immunoglobulin (IVIg) ...[2]. ... See full document

5

Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies

Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies

... of anti-D immunoglobulin are often lacking in most settings in ...human Anti-D immunoglobulin prophylactically in pregnancy should not detract from the most expedient approach to further the ... See full document

9

Scrub typhus with multi organ dysfunction syndrome and immune thrombocytopenia: a case report and review of the literature

Scrub typhus with multi organ dysfunction syndrome and immune thrombocytopenia: a case report and review of the literature

... Scrub typhus is a rickettsial zoonotic disease transmitted by mites and caused by Orientia tsutsugamushi [1]. Scrub typhus is a severe public health problem that af- fects mainly Asia-Pacific areas; scrub typhus ... See full document

5

A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report

A serious thrombotic event in a patient with immune thrombocytopenia requiring intravenous immunoglobulin: a case report

... several treatment options, including corticosteroids, immunosuppressive agents, anti-D, thrombopoietin agonists, splenectomy, and intravenous immunoglobulin ...first-line treatment, especially ... See full document

6

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

... of treatment, while the ROMI trial allowed dose reduction or discontinuation of ITP medica- tions during the first 12 weeks of treatment, which may have impacted platelet ... See full document

9

T cell immune abnormalities in immune thrombocytopenia

T cell immune abnormalities in immune thrombocytopenia

... relapsed ITP patients, the Th1-type cytokine spectrum returns to the dominant position after treatment with dexamethasone [28]. IL-18, a member of the IL-1 cytokine family, is widely expressed in ... See full document

6

Recurrent Immune Thrombocytopenia After Influenza Vaccination: A Case Report

Recurrent Immune Thrombocytopenia After Influenza Vaccination: A Case Report

... demonstrated thrombocytopenia of 2000/μL, with no other ...IVIG treatment, the child was further treated with oral prednisone and later with pulse methylprednisolone therapy, with complete resolution of the ... See full document

7

Immune mediated thrombocytopenia of malaria

Immune mediated thrombocytopenia of malaria

... significant immune complex binding. The thrombocytopenia that complicates at least some malarial infections is caused by immune mechanisms; specific IgG binds to platelet-bound malaria antigen ... See full document

6

Show all 10000 documents...